| A novel fatty acid-binding protein 5 and 7 inhibitor ameliorates oligodendrocyte injury in multiple sclerosis mouse models A Cheng, W Jia, I Kawahata, K Fukunaga EBioMedicine 72, 2021 | 39 | 2021 |
| Fatty acid-binding protein 7 triggers α-synuclein oligomerization in glial cells and oligodendrocytes associated with oxidative stress A Cheng, Y Wang, Y Shinoda, I Kawahata, T Yamamoto, W Jia, ... Acta Pharmacologica Sinica 43 (3), 552-562, 2022 | 23 | 2022 |
| The role of CaMKII and ERK signaling in addiction W Jia, I Kawahata, A Cheng, K Fukunaga International Journal of Molecular Sciences 22 (6), 3189, 2021 | 23 | 2021 |
| Sodium butyrate mediates histone crotonylation and alleviated neonatal rats hypoxic–ischemic brain injury through gut–brain axis X He, T Zhang, Y Zeng, P Pei, Y Liu, W Jia, H Zhao, M Bi, S Wang Frontiers in Microbiology 13, 993146, 2022 | 17 | 2022 |
| Impaired acquisition of nicotine-induced conditioned place preference in fatty acid-binding protein 3 null mice W Jia, G Wilar, I Kawahata, A Cheng, K Fukunaga Molecular Neurobiology 58, 2030-2045, 2021 | 16 | 2021 |
| Impact of fatty acid-binding proteins in α-synuclein-induced mitochondrial injury in synucleinopathy A Cheng, W Jia, I Kawahata, K Fukunaga Biomedicines 9 (5), 560, 2021 | 12 | 2021 |
| Fatty acid-binding proteins 3 and 5 are involved in the initiation of mitochondrial damage in ischemic neurons Q Guo, I Kawahata, A Cheng, H Wang, W Jia, H Yoshino, K Fukunaga Redox Biology 59, 102547, 2023 | 11 | 2023 |
| Fatty acid-binding proteins: their roles in ischemic stroke and potential as drug targets Q Guo, I Kawahata, A Cheng, W Jia, H Wang, K Fukunaga International journal of molecular sciences 23 (17), 9648, 2022 | 9 | 2022 |
| Epsin2, a novel target for multiple system atrophy therapy via α-synuclein/FABP7 propagation A Cheng, I Kawahata, Y Wang, W Jia, H Wang, T Sekimori, Y Chen, ... Brain 146 (8), 3172-3180, 2023 | 4 | 2023 |
| α‐Synuclein decoy peptide protects mice against α‐synuclein‐induced memory loss Q Guo, I Kawahata, W Jia, H Wang, A Cheng, Y Yabuki, N Shioda, ... CNS Neuroscience & Therapeutics 29 (6), 1547-1560, 2023 | 4 | 2023 |
| Pharmacological inhibition of FABP7 by MF 6 counteracts cerebellum dysfunction in an experimental multiple system atrophy mouse model A Cheng, W Jia, DI Finkelstein, N Stefanova, H Wang, T Sasaki, ... Acta Pharmacologica Sinica 45 (1), 66-75, 2024 | 2 | 2024 |
| Amelioration of nicotine-induced conditioned place preference behaviors in mice by an FABP3 inhibitor W Jia, I Kawahata, A Cheng, T Sasaki, T Sasaoka, K Fukunaga International Journal of Molecular Sciences 24 (7), 6644, 2023 | 2 | 2023 |
| Epsin2, a novel target for multiple system atrophy therapy via regulating α-synuclein propagation associated with FABP7 A Cheng, Y Wang, T Sekimori, W Jia, Y Chen, DI Finkelstein, I Kawahata, ... bioRxiv, 2022.06. 16.496509, 2022 | | 2022 |
Kohji FukunagaTohoku University在 tohoku.ac.jp 的电子邮件经过验证
Kohji FukunagaTohoku University在 tohoku.ac.jp 的电子邮件经过验证
An ChengUniversity of California, San Francisco在 ucsf.edu 的电子邮件经过验证